Improving Market Access Insights and Operations through Vendor Consolidation

Traditionally, pharmaceutical manufacturers chose an individual solution to address each of their market access needs. They selected one vendor for managing contracts, another solution for channel data, yet another for measuring product profitability and so-on. Unfortunately, this approach breaks down when trying to implement and measure critical market access processes including contract performance management, inventory management, channel optimization, gross-to-net forecasting, and ensuring patient initiation and adherence to therapy.

Increasingly, manufacturers are taking a platform-centric approach and looking to drive all of their market access applications and decisions off of a unified platform containing payer, channel, patient and product data. Download below!